Nureca Ltd. · NSE:NURECA
Nureca — FY2022 Earnings Presentation
31 slides from Nureca's earnings presentation, May 2022
Slide 1: Earnings Presentation May 2022
Think. Feel. Create. Earnings Presentation Ma y 2 0 2 2
Slide 2: Disclaimer
Disclaimer NURECA LIMITED T he Pres entat io n is to prov i de t he general ba c k gro und inf o rma tion a bout the Company ’ s a ctiv iti es as at the dat e of the Pres entat ion. T he inf o rmatio n conta ined herei n is f o r genera l inf o rmation purpo s es o nl y and ba s ed o n es timat es a
Slide 3: Nureca Limited: leading digital healthcare and wellness solutions provider
NURECA, 2021 ₹ 340 CR NURECA LIMITED is a leading Digital healthcare and wellness Listed On Stock Ex changes GMV For FY22 Solutions provider ₹ 263 CR 50+ CHRONIC Total Revenue For USFDA Approved DISEASES FY22 Products LIFESTYLE & FITNESS ₹ 66 CR ₹ 45 CR ORTHOCARE Adjusted EBITDA PAT For FY22 For FY2
Slide 4: Management Commentary
Management Commentary NURECA LIMITED “For us at Nureca, FY2021-22 has been an eventful year. We have taken meaningful strides towards realising our mission of creating a universal healthcare platform supported by quality home healthcare products for our customers. A significant milestone for the Com
Slide 5: Management Commentary
Management Commentary NURECA LIMITED “As Aryan mentioned, FY22 has really been an eventful year for us. Along with our Dr Trust 360 app and Offline expansion, we also expanded our product range. During the 1st half of the year, we launched products in the lucrative Nutraceuticals market under our Dr
Slide 6: Our growing customer base
Our growing customer base NURECA LIMITED CUSTOMER BA SE STEA DY Our customer base has (CUMULATIVE) * IMPROV EMENT grown exceptionally over the IN REPEA T (000’) last 4 years which is a result of CUSTOMER Returning visitors to remarkable quality of our 10,683 our website products that led to word-of-
Slide 7: Performance Highlights
Performance Highlights NURECA LIMITED Financial Highlights GMV for the FY22 at Rs. 3,403mn as compared to Rs. 2,994mn in FY21, an increase of 14% Operating Revenue was Rs. 2,555mn in FY22 as compared to Rs. 2,135mn in FY21, an increase of 20% Adjusted EBITDA was Rs. 664mn as compared to Rs. 64
Slide 8: Key Performance Indicators
Key Performance Indicators NURECA LIMITED Strong GMV Growth (INR mn) 3,403 2,994 Revenue for the year grew faster than GMV driven by better realization 1,281 790 Overall, demand remains robust in Q4 which is visible in 14 % strong growth of 29% over the same quarter last year. YoY Chip shortag
Slide 9: Key Performance Indicators
Key Performance Indicators NURECA LIMITED ADJUSTED EBITDA & EBITDA MARGIN The Gross margins for the full year was 48.1% compared (INR mn) to 53.4% in FY21. 30% 664 644 Our Gross margins for the full year were down by 500 22% basis points due to inflation in input cost, currency 26% fluctuation a
Slide 10: Key Performance Indicators
Key Performance Indicators NURECA LIMITED EPS 62 45 EPS for the year was at Rs. 45, down 27% from last year mainly due to a higher base as a result of the IPO which led to the higher number of shares 27 % Our ratios continue to remain robust, but we expect 4 9 9 YoY them to be rationalized and c
Slide 11: Financials – Income Statement
Financials – Income Statement NURECA LIMITED (INR mn) Particulars Q4'FY22 Q4'FY21 YoY Q3'FY22 QoQ FY22 FY21 YoY Revenue from operations 410 318 29% 481 -15% 2,555 2,135 20% Other Income 17 13 34% 17 -1% 77 28 173% Total Revenue 428 331 29% 498 -14% 2,632 2,163 22% Cost of Goods Sold 259 164 57% 293
Slide 12: Offline expansion – Progressing steadily
Offline expansion – Progressing steadily NURECA LIMITED 120+ 9, 000+ Distributors Retail outlets covered Offline team expansion, promotion and brand-building activities: 012
Slide 13: Offline expansion – Progressing steadily
Offline expansion – Progressing steadily NURECA LIMITED 120+ Distributors 9, 000+ Retail outlets covered 22 States & UTs covered Our Presence 013
Slide 14: Expanding Our Presence In Wellness And Preventive Healthcare Market
Expanding Our Presence In Wellness And NURECA LIMITED Preventive Healthcare Market Strong Product Pipeline We launched total 74 SKUs in FY22 taking the total number of SKUs launched n the market to 216 250 We continue to expand our presence in the nutraceuticals vertical with the latest launch of a
Slide 15: New Product Launches
New Product Launches NURECA LIMITED “ Trumom ” – Organic Baby Care Range To address the increasing and ever-changing demands of quality-conscious parents who prefer safe and efficacious hygiene products for their babies, Trumom has expanded its range of baby products. Enriched with Organic ingredien
Slide 16: New Product Launches (Cont'd)
New Product Launches (Cont’d) NURECA LIMITED Trumom Baby wipes Our wipes are enriched with the power of organic ingredients including Lavender + Lemon Oils to provide gentle & effective cleaning while nourishing the skin. Premium quality, durability, softness, and mild fragrance are other USPs that
Slide 17: New Product Launches (Cont'd)
New Product Launches (Cont’d) NURECA LIMITED Trumom Baby Soap We have launched baby soap that contains the goodness of organic almond, apricot, lavender, jojoba oil, and Shea butter. Our soap gives a rich creamy lather that gently cleanses and rinses easily. It has been specially developed for nouri
Slide 18: Dr Trust Nutrition Range
Dr Trust Nutrition Range NURECA LIMITED Dr Trust Nutrition Calcium Enriched with the power of Moringa & Hadjod, we have launched *Calcium* supplement as a complete nutrient for bones & teeth health. This is not just a plain calcium tablet but, it also provides the benefits of Magnesium, Zinc, Vitami
Slide 19: Smart Products Portfolio
Smart Products Portfolio - *Our devices are clinically accurate USFDA & CE Approved NURECA LIMITED Body composition BP monitors ECG monitor Smartwatches Glucometers scales Health metrics captured from devices: Weighing scale* BP Monitor* Glucometer* ECG monitor* Smartwatches Bone Mass Health Monitor
Slide 20: Our AI driven platform
Our AI driven platform – NURECA LIMITED 020
Slide 21: Our connected health solution
Our connected health solution - NURECA LIMITED Aggregate A unified app to track all the health metrics and vitals collected from various DrTrust devices Access Consult specialists from top hospitals, book diagnostics and lab services Interact Share real time health data with doctors nutritionist and
Slide 22: Holistic Solutions
- – Holistic Solutions NURECA LIMITED On our smart healthcare platform, Dr Trust 360, we have a series of value-added features: Virtual Care & Telehealth Dr Trust 360 now makes it easy to consult leading doctors at the comfort and convenience of your home via a video call. Our nutrition plans, combi
Slide 23: Holistic Solutions
- – Holistic Solutions NURECA LIMITED On our smart healthcare platform, Dr Trust 360, we have a series of value-added features: Measure health data Dr Trust 360 now makes it easy to measure weight, blood pressure, blood sugar, etc via DrTrust devices Analyse Dr Trust 360 platform now enables user to
Slide 24: Holistic Solutions: new features
- – Holistic Solutions NURECA LIMITED During the quarter, we have added more value-added features: Risk Assessments* HbA1c* A longer-term To understand the risk metric for our profile of users – Glucometer users to currently, we have better understand launched the diabetic their trends. it is risk s
Slide 25: Holistic Solutions: Diet 360 and Learn with meaning
- – Holistic Solutions NURECA LIMITED During the quarter, we have added more value-added features: Diet 360* Learn with meaning* Introduced blogs, yoga & mindfulness modules from top experts for users to better Diet plans for our users, manage their health for all their needs. This is a mix of both
Slide 26: Chronic and Orthopedic Market
Chronic and Orthopedic Market NURECA LIMITED CHRONIC DISEASE PRODUCTS MARKET (INR Cr) Increasing Chronic diseases contribution to the 1,163 deaths, higher spending power and availability of affordable healthcare products is driving the 683 demand for chronic disease management products at their home
Slide 27: Competitive Landscape
Competitive NURECA LIMITED Landscape Respiratory Care Nebulizer √ √ √ √ x √ Pulse Oximeter √ x x √ x √ Cardiac Care BP Monitor √ √ x √ x √ Heart Rate Monitor √ √ x √ x x Diabetes Care Blood Glucometer √ x x x x √ Niche Categories Massagers √ √ x √ x x Baby Care √ x √ √ x x Others Personal Scales √ √
Slide 28: What Makes Nureca Different?
What Makes Nureca Different? NURECA LIMITED Product Quality • International standards quality and design of the products Regulatory Compliance • Our products are manufactured to be safe, accurate, long-lasting and compliant to national and international regulations. Our chronic monitoring devices ar
Slide 29: Business Outlook
Business Outlook NURECA LIMITED • Strong focus on connected devices for remote patient monitoring ADDING PRODUCTS AND • Expansion into supplement and nutrition categories CATEGORIES • Create a pipeline of innovative healthcare and wellness products • A strong customer base for cross-selling of diffe
Slide 30: Shareholder Information
Shareholder Information NURECA LIMITED Shareholding as on 31st March 2022 Share Information as on 31st March 2022 Others NSE Ticker NURECA 12.6% Other DII BSE Ticker 543264 3.9% IPO Listing Date 25th February 2021 Mutual Funds Market Cap (INR Cr) 1,368 1.4% Shares Outstanding 1,00,00,175 FII 12.2% 3
Slide 31: Thank You
Thank. You. INVESTOR RELATIONS AT NURECA Gurvikram Singh cs@nureca.com Ernst & Young Rahul Thakur Rahul.thakur@in.ey.com Off ice No. 101, Udy og Bhav an, Sonaw ala Lane, Goregaon East, Mumbai, Maharashtra - 400063 Drtrust.in Drtrust360.com